Mortality predictors in CV implantable device infection ID'd

Mortality predictors in CV implantable device infection ID'd
Infective endocarditis related to a cardiovascular implantable electronic device, corticosteroid therapy, and other comorbidities are tied to reduced short- and long-term survival, according to a study published in The American Journal of Cardiology.

(HealthDay)—Infective endocarditis related to a cardiovascular implantable electronic device (CIED), corticosteroid therapy, and other comorbidities are tied to reduced short- and long-term survival, according to a study published in The American Journal of Cardiology.

Ammar Habib, M.D., from the Mayo Clinic in Rochester, Minn., and colleagues retrospectively reviewed 415 patients with CIED infection who were admitted to Mayo Clinic from January 1991 to December 2008. Medical records and the United States Social Security Index were used to ascertain survival data.

The researchers found that at a mean follow-up of 6.9 years, 243 patients were still alive. Heart failure (odds ratio [OR], 9.31), corticosteroid therapy (OR, 4.04), and presentation with CIED-related infective endocarditis (OR, 5.60) were associated with increased short-term mortality in a multivariate model. Long-term mortality was associated with patient age (hazard ratio [HR], 1.20), (HR, 2.01), metastatic malignancy (HR, 5.99), corticosteroid therapy (HR, 1.97), renal failure (HR, 1.94), and CIED-related infective endocarditis (HR, 1.68) in a multivariate model.

"In conclusion, these data suggest that the development of CIED-related and the presence of comorbid conditions are associated with increased short- and long-term mortality in patients with CIED infection," the authors write.
Several authors report to the medical device industry.

More information: Abstract
Full Text (subscription or payment may be required)

add to favorites email to friend print save as pdf

Related Stories

Early surgery ups outcomes in infective endocarditis

Jun 28, 2012

(HealthDay) -- For patients with infective endocarditis and large vegetations, early surgery reduces death from any cause and embolic events, compared with conventional treatment, according to a study published ...

Recommended for you

Time to take notice and tackle heart failure

9 hours ago

Experts have sounded a call to action for policy makers at local, national, and international levels to promote heart failure prevention, improve heart failure awareness among healthcare professionals, ensure ...

Hopes dashed for an agent to prevent reperfusion injury

13 hours ago

The administration of an experimental agent known as TRO40303 to patients who have had a heart attack, with the hope of preventing tissue damage when impaired blood flow is corrected (reperfusion), was disappointingly ineffective ...

User comments